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“SPEED LIMITS:” STATES’
APPROACHES TO REGULATING ACCESS
TO METHAMPHETAMINE CHEMICAL PRECURSORS
WITH STATUTES AND REGULATIONS LIMITING
PSEUDOEPHEDRINE AVAILABILITY
SAMANTHA S. MCKINLEY† AND JOSEPH L. FINK III††

I.

INTRODUCTION

Methamphetamine is a stimulant medication lawfully distributed under
the brand name Desoxyn®.1 According to the federal Controlled Substances Act,2 the United States Drug Enforcement Administration (DEA)
classifies methamphetamine as a classified Schedule II substance.3 Illicit
methamphetamine comes in a variety of forms and is known by many
names. Some of the most common street names include “meth,” “crank,”
“crystal,” and “speed.” Typically, methamphetamine is obtained as a white,
odorless, bitter tasting powder or crystal substance. However, methamphetamine can be made in other forms. The most common route of administration is oral, although methamphetamine can be smoked, injected, or
snorted.4 Each particular method of administration will affect the onset of
the drug’s effect differently, making direct injection and snorting the
favorites for illicit use because these routes allow for fast onset of effects.
It is a powerfully addictive drug, which is easy to make and relatively
inexpensive to purchase.
In the early 1980s, methamphetamine abuse was a small problem
limited to the West Coast. However, over the last two decades the problem
has exploded with an eastward drift, and now touches virtually the entire
United States. It has devastated many small rural communities and is
†
Third-year professional student, University of Kentucky College of Pharmacy. B.S. 1987,
University of Florida; J.D. 1991, Whittier Law School; D.C. 1999, Northwestern Health Sciences
University. Member of the Florida Bar.
††
Professor of Pharmacy, Professor of Public Health, and Professor of Health Administration,
University of Kentucky. B.S. Pharm., 1973, Philadelphia College of Pharmacy and Science; J.D.
1973, Georgetown University Law Center. Member of the Kentucky and Pennsylvania Bars.
1. Merck Manuals Online Med. Library, Drug Names: Generic and Trade,
http://www.merck.com/mmhe/drugnames-index/trade/d.html (last visited June 20, 2007).
2. Controlled Substances Act, 21 U.S.C. §§ 801-971 (2000).
3. 21 U.S.C. § 812(c) (2000).
4. U.S. Drug Enforcement Admin., DEA Briefs and Background, Drug & Drug Abuse, Drug
Description, http://www.dea.gov/concern/methamphetamine_factsheet.html#3 (last visited June
13, 2006).
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quickly moving into urban areas. The National Institute on Drug Abuse
estimates that more than 1.2 million Americans have tried methamphetamine.5 The drug is seductive and the initial payoffs are big.
Methamphetamine gives the buyer more bang for the buck than any
other drug on the street. A user can feel the affects of taking methamphetamine for eight to twenty-four hours depending upon individual tolerance.6
This energy boost is so alluring that it has even captured the interest of new
young mothers.7 It helps new moms with weight loss, boosts energy levels
to create Superwoman status and lifts inhibitions to raise self-esteem.8 The
use of methamphetamine transcends all boundaries of social or economic
classes and can be found in the hands of teenagers, factory and construction
workers, corporate risers, and stay-at-home mothers. For these reasons, it
should be no surprise that methamphetamine has captured the focus of law
enforcement agencies and lawmakers across this country.
II. DIFFERENTIATING BETWEEN METHAMPHETAMINE,
EPHEDRINE, AND PSEUDOEPHEDRINE
The active ingredient for synthesizing methamphetamine can be either
ephedrine or pseudoephedrine.9 When snorted, swallowed, injected, or
smoked, the cooked cold products produce a long lasting high and euphoric
feeling. Although the exact mechanism of action is unknown, it is generally believed that methamphetamine causes the monoamine transporter to
reverse its direction of flow within the brain.10 This results in further
5. NAT’L INST. ON DRUG ABUSE, NIDA ADDICTION TREATMENT DISCOVERY PROGRAM 4,
available at http://www.drugabuse.gov/about/organization/DPMCDA/atdp/ATDP_2006_Guide.
pdf.
6. NAT’L INST. ON DRUG ABUSE, METHAMPHETAMINE ABUSE AND ADDICTION, available at
http://www.nida.nih.gov/PDF/RRMethamphetamineam.pdf.
7. Elizabeth Fish, Mother’s (Dangerous) Little Helper, BABYTALK, Apr. 2006 at 62,
available at http://www.parenting.com/mom/article10,19840,1175602,00.html.
8. Id.
9. U.S. Food and Drug Admin., Legal Requirements for the Sale and Purchase of Drug
Products Containing Pseudoephedrine, Ephedrine, and Phenylpropanoloamine, http://
www.fda.gov/cder/news/methamphetamine.htm (last visited Jan. 11, 2007).
10. See Annette E. Fleckenstein et al., New Insights into the Mechanisms of Action of
Amphetamines, 47 ANNUAL REV. PHARMACOLOGY TOXICOLOGY 681, 683 (2001) (explaining the
reverse transport of monoamines as a result of methamphetamine). Mechanism of action is the
action or process by which a pharmacologically active substance produces an effect on a living
organism or in a biochemical system. The Freedictionary.com, http://www.thefreedictionary.com/
p/mechanism+of+action (last visited Jan. 11, 2007). Monoamine transporter is a protein structure
involved in the movement of monoamines (substances with only one nitrogen group such as
norepinephrine, dopamine, and serotonin) in biological systems. STUART IRA FOX, HUMAN
PHYSIOLOGY 168-70 (8th ed. 2004). The synaptic cleft is the area of microscopic space between
the pre-synaptic axon terminal and the post-synaptic cell. Id. At 168. A neurotransmitter is a
chemical substance “that is released from the axon terminal of a presynaptic neuron on excitation,
and that travels across the synaptic cleft to either excite or inhibit a target cell” to cause effect.
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release of monoamines to the synapse and blocks the re-uptake of these
neurotransmitters causing them to remain longer within the synaptic cleft.11
However, the desirable upfront benefits are only a part of a stimulant
use story that often carries an unhappy ending. One neuropsychiatrist
explained this well when he said, “[m]eth first stimulates and then blows
out the brain’s pleasure centers until, finally . . . ‘nothing feels good.’”12
Methamphetamine is an extremely difficult addiction to overcome and
chronic use causes a dramatic shift in a person’s physical appearance.
Methamphetamine use will in short order rot teeth, wrinkle skin, and create
an intense itching, which will lead to scratching and scarring. It can convert
a young, full-faced person to a desiccated, aged, toothless person with a
face covered with bloody, open sores in little time.
Methamphetamine is fairly easy to manufacture in rudimentary laboratories from commonly available chemicals including non-prescription
decongestants, such as ephedrine and pseudoephedrine. Methamphetamine
is a synthetic stimulant drug used for both medicinal and illegal recreational
purposes. Like most stimulants, methamphetamine can produce a very
strong euphoria and thus carries a great potential for addiction.

Methamphetamine
Source: structures taken from www.chemicalforums.com.13

BENJAMINE FRANK MILLER & CLAIRE BRACKMAN KEANE, ENCYCLOPEDIA & DICTIONARY OF
MEDICINE, NURSING AND ALLIED HEALTH 1025 (5th ed. 1992).
11. See Evan L. Riddle et al., Mechanisms of Methamphetamine-Induced Dopaminergic
Neurotoxicity, 8 AM. ASS’N PHARMACEUTICAL SCIENTISTS E413, E413-14 (2006) (indicating
that methamphetamine prevents re-uptake and causes an increased concentration of
neurotransmitter).
12. Virginia Heffernan, An Illegal Drug From Labs That Can’t Be Shut Down, N.Y. TIMES,
Feb. 14, 2006, at B8.
13. ChemicalForums.com, The Chemical Structure of Methamphetamine, http://www.
chemicalforums.com/index.php?page=molecules#methamphetamine (last visited Jan. 11, 2007).
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Both ephedrine and pseudoephedrine are sympathomimetic amines
commonly used as decongestants.14 Each is marketed in many over-thecounter products in a hydrochloride or sulfate salt form. Ephedrine is a
chemical alkaloid derivative of Ephedra plants. Ephedrine exhibits a phenomenon known as “optical isomerism,” and has two chiral centers.15
On the other hand, pseudoephedrine is an isomer of ephedrine. In this
way, ephedrine and pseudoephedrine are very similar and differ regarding
chiral positioning. However, this slight structural difference appears to
make pseudoephedrine the preferred decongestant because it has far lower
central nervous system activity when compared to other Ephedra alkaloids
including ephedrine.16

Ephedrine

Pseudoephedrine

Source: structures taken from Remington.17
The chemical structures of ephedrine and pseudoephedrine are very
similar to that of methamphetamine. In fact, the primary difference is the
presence of the oxygen on the alcohol group of the benzylic position in the
compound. The similarity in chemical structure to amphetamines along
with availability and ease of obtaining them has made ephedrine and/or

14. Brian B. Hoffman, Catecholamines, Sympathomimetic Drugs, and Adrenergic Receptor
Antagonists, in GOODMAN & GILMAN’S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS 23738 (Joel G. Hardman & Lee E. Limbird eds., 10th ed. 2001). Sympathomimetic amines refer to
chemical substances that contain a nitrogen group and whose effects mimic the effects seen with
activation of the sympathetic (fight or flight) nervous system liberating adrenaline like substances.
Id. at 216; REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY 1379 (21st ed. 2005).
15. REMINGTON, supra note 14, at 171, 187.
16. Tga.gov.au, Core Pseudoephedrine Product Information, http://www.tga.gov.au/npmeds/
pi-pseudoephedrine.rtf (last visited Jan. 11, 2007).
17. REMINGTON, supra note 14, at 1385, 1387.
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pseudoephedrine a perfect and highly sought after chemical precursor for
the illegal manufacturing of methamphetamine.
III. THE MAKING OF METHAMPHETAMINE
The processing required to make methamphetamine from precursor
substances is easier and more accessible than ever. The chemical reactions
created in the cooking process serve the purpose to remove the oxygen
group from the hydroxyl group on the pseudoephedrine, which is the only
structural difference between pseudoephedrine and methamphetamine (see
illustrations above). However, the effects of methamphetamine are much
more potent and long lasting. Many different recipes for conversion to
methamphetamine can be found on the Internet. Although most sites are
not trustworthy, almost every method involves highly dangerous chemicals
and processes.
A. THE ESSENTIALS
The beginning ingredient is usually an over-the-counter tablet product
containing pseudoephedrine because it produces the highest quantity and
purity of methamphetamine.18 Single ingredient products are preferred,
again because of quantity and purity, but are not absolutely necessary. The
tablets are then dissolved in a nonaqueous solvent like alcohol to remove
the active ingredient from the excipients.
The recovered product is then processed by one of two usual methods.
Most production methods involve the hydrogenation of the hydroxyl group
on the ephedrine or pseudoephedrine compound, a form of oxidation
chemical reduction. One of the most popular methods for converting
pseudoephedrine or ephedrine to methamphetamine in the United States
uses red phosphorus and iodine in the reaction to extract the methamphetamine base. This forms hydroiodic acid and is a fairly dangerous process
from which many methamphetamine cooks have sustained deadly burns.
Another popular method is similar to a Birch reduction reaction, in
which sodium or anhydrous ammonia (often available as farm fertilizer)
and lithium metal (from lithium batteries) are mixed with the pseudoephedrine to create the methamphetamine base directly. This has also been
called the “Nazi Method” because it supposedly mirrors a methamphetamine-making procedure followed by the Germans during World War II.19

18. Food Mktg. Inst., Facts About Methamphetamine Precursors 1, www.fmi.org/gr/
Methamphetamine.pdf.
19. J. Steven Cline, Illegal Methamphetamine Laboratories as a Public Health Hazard, 71
POPULAR GOV’T (Special Issue) 24, 24 (2005).
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This reduction process is extremely dangerous since the alkali metal and
liquid anhydrous ammonia are both extremely reactive and the ammonia is
very susceptible to explosion when the reactants are added.
B. OTHER CHEMICALS AND SUPPLIES USED IN MANUFACTURING
METHAMPHETAMINE
There are, however, many other products used in the making of methamphetamine. The exact mix affects the purity of the product. Some of
these products are precursor ingredients; others are supplies commonly used
in methamphetamine production and are by no means comprehensive.20
Precursors include products containing pseudoephedrine, acetone, ether
(e.g., engine starter fluid), rubbing or isopropyl alcohol, methanol (e.g.,
gasoline), toluene (e.g., brake cleaner), red phosphorous (e.g., road flares
and matchbook covers), iodine, sodium hydroxide or lye, white vinegar,
lithium (e.g., batteries), anhydrous ammonia (e.g., fertilizer), sulfuric acid
(e.g., drain cleaner), rock salt, and paint thinner.21 Some of the supplies
used include aluminum foil, coffee filters, propane tanks, pyrex or corning
dishes, jugs, bottles, funnels, cheesecloth, a blender, rubber tubing, paper
towels, rubber gloves, gas can, tape or clamps, hotplate, strainer, and books
(e.g., “How to Make Methamphetamine”).22
C. THE ENTICEMENTS
To this day super laboratories operated by drug traffickers in Mexico or
California remain the largest sources and producers of methamphetamine
for the United States and rely more on diverted shipments of laboratory
grade precursors rather than over-the-counter products.23 Small, make-shift
clandestine laboratories have flourished, in part because the cooking
process for methamphetamine is quick, simple, and inexpensive. Clandestine laboratory operations can produce $1,000 of methamphetamine from

20. Precursor ingredients refer to substances from which more biologically active substances
are formed. MILLER & KEANE, supra note 10, at 1202. See Methamphetamine Watch Program,
Background on Methamphetamine, http://www.methwatch.com/background/what_is_methamphetamine_index.aspx#3 (last visited Jan. 25, 2006) (explaining that methamphetamine can be
made from commonly available, legitimate household products).
21. Methamphetamine Watch Program, Background on Methamphetamine, supra note 20;
StreetDrugs.org, Methamphetamine Labs, htpp://www.streetdrugs.org/methamphetaminelabs.htm
(last visited Jan. 25, 2006).
22. Id.
23. MICHELLE R. CHESLEY, METHAMPHETAMINES: AN EPIDEMIC OF CLANDESTINE LABS
AND HEALTH RISK 4 (1999), http://www.health.state.mn.us/divs/eh/methamphetamine/lab/
mchesley.pdf.
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approximately $100 of materials.24 With this kind of lucrative profit
margin, many people are lured into manufacturing methamphetamine. The
average methamphetamine “cook” annually teaches ten other people how to
make the drug.25
D. THE DANGERS
The portion of methamphetamine that is made domestically in wellhidden mobile laboratories has cost taxpayers millions of dollars in cleanup, law enforcement, rehabilitation efforts, foster care, and medical aid. 26
Regardless of which production method is used, each method has inherent
dangers. Many of the chemicals used are caustic or corrosive, and some of
the processes create noxious and harmful fumes. The cooking process
produces waste in liquid and solid form and carries the risk of producing a
dangerous explosion. This waste is most often discarded in a way that
contaminates the soil and groundwater. Thus, the production process is a
danger to the environment, not just to those involved in the cooking
process.
Because of the dangers, specially trained professionals, wearing full
hazardous materials protection suits, must be used to dismantle a methamphetamine laboratory. It is estimated that for every pound of methamphetamine produced, five pounds of hazardous waste are also produced in the
cooking process.27 This type of clean up and hazard imposes a great
financial burden on society.
Domestic laboratories also pose a huge danger to communities, law
enforcement and children. Thousands of young and innocent children are
suffering the consequences of the methamphetamine epidemic. In the worst
cases, these children endure horrible abuse and even die at the hands of
their own addicted parents. Many others are neglected while their parents
are too high to notice. In the best cases, the children are discovered and
then shuttled between relatives and foster homes, competing in a life filled
24. Joseph T. Rannazzisi, Deputy Chief, Office of Enforcement Operations, Drug
Enforcement Admin., Comprehensively Combating Methamphetamine: Impact on Health and the
Environment (Oct. 20, 2005), http://www.usdoj.gov/dea/speeches/s102005.html.
25. DrugFree.org, Methamphetamine Frequently Asked Questions, http://www.drugfree.org/
Portal/DrugIssue/MethamphetamineResources/methamphetamine_faq.html (last visited May 30,
2007).
26. See WhiteHouseDrugPolicy.gov, FactSheet: Impact of Methamphetamine on the Environment, http://www.whitehousedrugpolicy.gov/news/press05/methamphetamine_environment_
factsheet.html (last visited May 30, 2007) (discussing the costs of methamphetamine).
27. Armand McClintock, Assistant Special Agent, Indianapolis District Office Drug
Enforcement Admin., Fighting Methamphetamine in the Heartland: How Can the Federal
Government Assist State and Local Efforts? (Feb. 6, 2004), http://www.usdoj.gov/dea/pubs/
cngrtest/ct0220604.htm.

1224

NORTH DAKOTA LAW REVIEW

[VOL . 82:1217

with broken promises, violence, grief, and distrust. Many of these children
are easily lost back into a life of crime or become reliant on society to
support their livelihood. Many local and state police forces have responded
by creating specialized task forces educated in responding to methamphetamine-involved cases. Also, many local communities have initiated task
forces to assist local authorities, citizens, and child victims.
IV. CHANGE IN LEGISLATION
There are more than 700 over-the-counter products that contain
ephedrine and/or pseudoephedrine, which could potentially be moved
behind counters.28 However, the majority of enacted legislation focuses
only on the solid dosage forms of these products, and may even explicitly
exempt any liquid formulations.29 Liquid formulations may be exempt
from tight regulation because, although chemists have made batches of
methamphetamine from conversion of the liquid pseudoephedrine products,
the process is more complex and less well known.30 One can speculate that
current illicit drug manufacturers are reluctant to spend the energy and
resources for liquid formulation conversion when there has been such easy
and convenient access to solid forms and a history of cooking guidelines.
However, as regulations and restrictions curtail methamphetamine production, liquid formulations may become a greater concern.
A. SHARED JURISDICTION
Partially as a result of the rapid eastward spread of methamphetamine,
the Comprehensive Methamphetamine Control Act of 199631 (CMA) was
signed into law on October 3, 1996.32 The CMA’s primary purpose was to
control the distribution of certain chemical precursors that could be used to

28. See In.gov, List Containing Over-the-Counter Products that Contain Pseudoephedrine
and Ephedrine, http//www.in.gov/cji/methfreeindiana/Product_List.pdf (listing 777 products and
disclaiming that this list is exhaustive).
29. Combat Methamphetamine Epidemic Act of 2005, Pub. L. No. 109-177, 120 Stat. 256
(codified as amended in scattered sections of 21, 22, and 42 U.S.C.); Comprehensive
Methamphetamine Control Act of 1996, Pub. L. No. 104-237, 110 Stat. 3099 (codified as
amended in scattered sections of 21 and 28 U.S.C.); NAT’L ALLIANCE FOR MODEL STATE DRUG
LAWS, RESTRICTIONS ON OVER-THE-COUNTER SALES/PURCHASES OF PRODUCTS CONTAINING
PSEUDOEPHEDRINE, available at http://www.natlalliance.org/pdfs/Pseudoephedrine%20Products
%20Overview%20%20November%202006%20Revised%20Version.pdf
[hereinafter
STATE
RESTRICTIONS].
30. Lee Rood, Current Controls Have Had Little Effect, DESMOINESREGISTER.COM, Jan. 9,
2005, http://Desmoinesregister.com/apps/pbcs.dll/article?AID=/20050109//NEWS01/501090350.
31. Comprehensive Methamphetamine Control Act, Pub. L. No. 104-237, 110 Stat. 3099
(1996) (codified as amended in scattered sections of 21 U.S.C.).
32. Id.
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manufacture methamphetamine.33 These precursors include ephedrine,
pseudoephedrine and phenylpropanolamine which could be found in many
over-the-counter products.34 To avoid interfering with access to many
common over-the-counter products, CMA specifically exempted “ordinary”
over-the-counter sales of such products from its scope.35 However, the
methamphetamine problem continued to grow despite this legislative
boundary.36
In the wake of spreading illegal and dangerous methamphetamine
laboratories and no federal law guidance, one by one the states began to
enact restrictions on the sale of ordinary over-the-counter cold products
containing ephedrine and pseudoephedrine.37 In addition, many pharmacies
and other retailers elected to limit consumer access to pseudoephedrine
products irrespective of discrepancies in individual state laws and the lack
of federal law.38 Many companies like Target and Wal-Mart voluntarily
placed the products behind the counter early on in the history of
methamphetamine restrictions.39
In spite of such voluntary restrictions and added responsibility for
pharmacies and retailers, methamphetamine crimes continue to rise.40 Due
to the lack of federal law, methamphetamine producers could stockpile precursor supplies in states that did not have restrictions.41 In addition, even
states that require sales logs do not have any cross reference structure in
place, leaving an opportunity for methamphetamine makers to shop at many
local outlets for their source of precursors.42

33. § 401(d), 110 Stat at 3108.
34. Id.
35. Id.
36. Derick Quenzer & Steve Suo, How Legislation Changed Meth Purity, available at
http://www.house.gov/larsen/methamphetamine/pdf/1004methamphetamine_purity.pdf.
37. See generally STATE RESTRICTIONS, supra note 29 (reviewing state bills and/or regulations establishing or enhancing restrictions on over-the-counter sales/purchases of pseudoephedrine).
38. Steve Ivey, Anti-Methamphetamine Bill Would Place Restrictions on Pseudoephedrine,
CHI. TRIB., Nov. 26, 2005, at 1, available at http://www.redorbit.com/news/health/314171/
antimethamphetamine_bill_would_place_restrictions_on_pseudoephedrine/index.html.
39. Id.
40. Quenzer & Suo, supra note 36.
41. Am. Pharm. Ass’n, Pseudoephedrine Diversion: Regulatory and Scientific Resources, 13
PARTNERS IN SELF-CARE 8-9 (Apr. 2005) [hereinafter Pseudoephedrine Diversion].
42. Id.
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The following chart demonstrates how the methamphetamine supply
has historically responded to legislative initiatives.43 As a result, at least in
part of this trend, the media and governmental officials have taken notice
and the federal government has been called to act.

43. Quenzer & Suo, supra note 36.
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B. NATIONAL RECOGNITION AND THE 2006 ENACTMENT OF THE
COMBAT METHAMPHETAMINE EPIDEMIC ACT OF 2005
The Combat Methamphetamine Epidemic Act of 2005 44 (CMEA) was,
in essence, Congress’s response to the cry for additional control in relation
to the methamphetamine epidemic.45 The purpose was to close the gaps of
the earlier CMA and provide centralized control to fight methamphetamine
abuse.46 However, loopholes still remained.47 To close some of the outstanding loopholes, Congress passed new federal requirements to control
the sales of pseudoephedrine as part of the USA PATRIOT Improvement
and Reauthorization Act 48 (PATRIOT Act) in March 2006.49
The CMEA was reauthorized and extended by Congress in the
PATRIOT Act.50 CMEA places ephedrine, pseudoephedrine and phenylpropanolamine in a new CSA category of “scheduled listed chemical
products.”51 Products falling into this new class are subject to sales
restrictions, storage requirements, and record keeping rules.52 Some of the
requirements went into effect on April 8, 2006,53 while others require
compliance by September 30, 2006.54 In a clarification to the American
Pharmacists Association (APA), the DEA stated that the new law is applicable to over-the-counter “sales” but does not apply to valid prescriptions

44. Combat Methamphetamine Epidemic Act of 2005, Pub. L. No. 109-177, 120 Stat. 256
(2006).
45. Pseudoephedrine Diversion, supra note 41, at 11.
46. Ryan Lenz, Anti-Methamphetamine Laws Pose Dilemma for States (Oct. 9, 2005),
http://officer.com/article/article.jsp?siteSection=6&id=26363.
47. Id.
48. USA PATRIOT Improvement and Reauthorization Act of 2005, Pub. L. No. 109-177,
120 Stat. 192 (2006) (codified in scattered sections of 18, and other titles of U.S.C.).
49. §§ 701-756, 120 Stat. at 256-77.
50. Id.
51. 21 U.S.C. § 802 (45)(A) (2006).
52. 21 U.S.C. § 830(d) (2006).
53. Id. Those changes effective April 8, 2006 impose a 3.6 grams daily sales limit, a 9.0
grams thirty day purchase limit, and require all non-liquid forms to be sold in blister packs or unit
dose packets or pouches. Id. In addition, mail-service pharmacies must verify patient’s identification before shipping the product, and are subject to a 7.5 gram thirty-day purchase limit. 21
U.S.C. § 830(e)(1)(A) (2006).
54. 21 U.S.C. § 830 (2006). The changes, which became effective September 30, 2006,
mandate that products must be placed behind a counter or in a locked cabinet, the seller must
maintain a written or electronic logbook, purchasers must present a photo identification and sign
the logbook, and sellers must self-certify to the U.S. Attorney General that their sales personnel
have been trained as required by regulations. 21 U.S.C. § 830(b) & (e) (2006). Of particular note,
sales of sixty milligram or less of pseudoephedrine are exempt from the logbook and identification
requirements. 21 U.S.C. § 830(e) (2006).
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for such products.55 Since September 30, 2006 the law also requires the
maintenance of a transaction logbook.56 Because CMEA is a federal
statute, states may, of course, impose more stringent requirements.
C. EMPLOYEE TRAINING UNDER THE CMEA
According to CMEA, all retailers of methamphetamine precursors must
have trained their employees on the new requirements by September 30,
2006, and have self-certified to the DEA that the training occurred.57 The
DEA developed the training program which consists of nineteen slides. 58
Retailers must use the content supplied by the DEA in the training of their
employees, but may supplement with additional material as they see fit or
which their particular state requires.59 These requirements are a part of the
“interim final regulation.”60 It has been speculated that consumers should
expect more changes regarding the logbook, training, and ways to address
privacy issues arising from the logbook utilization.61
D. SYNTHETIC DRUG CONTROL STRATEGY
On June 1, 2006, the Bush Administration went a step further in the
fight against methamphetamine and released the Synthetic Drug Control
Strategy (SDCS).62 The primary goal of SDCS is the reduction of methamphetamine.63 The strategy is to focus on the use and production of methamphetamine and on the non-medical use of controlled substance prescriptions.64 One of the keys to decreasing the methamphetamine epidemic is
cooperating with Mexico in reduction efforts and to prevent the import of
methamphetamine and its precursors across the border.65

55. Pharmacist.com, PSE Restrictions Working, but Methamphetamine Problems Continue,
http://www.pharmacist.com/articles/h_ts_1206.cfm (last visited July 22, 2006).
56. 21 U.S.C. § 830(e)(1)(A)(iii) (2006).
57. AM. PHAR. ASS’N, DEA INTERIM FINAL REGULATION: EPHEDRINE, PSEUDOEPHEDRINE,
AND PHENYLPROPANOLAMINE REQUIREMENTS 1 (2006), available at http://www.pswi.org/
Pseudoephedrine093006.pdf.
58. Id. at 6.
59. Id.
60. Id.
61. Ed Lamb, Methamphetamine Control Laws Open Door for Patient Counseling, 12
Pharmacy Today 18 (May 2006).
62. OFFICE OF NAT’L DRUG CONTROL POLICY, EXECUTIVE OFFICE OF THE PRESIDENT,
SYNTHETIC DRUG CONTROL STRATEGY, A FOCUS ON METHAMPHETAMINE AND PRESCRIPTION
DRUG ABUSE (2006), available at http://www.whitehousedrugpolicy.gov/publications/
synthetic_drg_control_strat/synth_strat.pdf [hereinafter SYNTHETIC DRUG CONTROL STRATEGY].
63. Id. at 5.
64. Id. at 5-6.
65. Id. at 16-17.
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The SDCS is a companion document to the President’s National Drug
Control Strategy and the CMEA. In addition, it includes detailed plans for
unprecedented cooperation with Mexico and other international governments to drastically reduce the flow of methamphetamine and precursors
into the United States.66 Besides a call for a fifteen percent reduction in
methamphetamine abuse in three years, the SDCS expects a twenty-five
percent reduction in domestic methamphetamine laboratories.67 Furthermore, the SDCS contains a three-prong approach to United States’
international efforts, including improving global intelligence regarding
precursors, effective implantation of the CMEA, and strengthening law
enforcement and border control.68
Over the last several years, there have been numerous stories in the
media highlighting how methamphetamine production can harm children. 69
Children are often used as cheap/free labor in the cooking process.70 Young
children are very vulnerable to the toxicity and poisoning and are often
victims rather than active participants in their parents’ or other adults’
illegal production of methamphetamine. A core element of the Bush
Administration response was supporting Drug Endangered Children (DEC)
alliances.71 DEC programs train first responders on the best way to help
protect children who are found in the vicinity of methamphetamine
laboratories.72 Many states have enacted DEC programs.73
V. THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS
Much of the information presented within the State Specific Provisions,
which will be discussed in Section VI, was compiled utilizing and relying
heavily upon the data and resources provided by the National Alliance for
Model State Drug Laws (Alliance) via its official website.74 The Alliance

66.
67.
68.
69.

Id. at 9.
Id. at 7.
SYNTHETIC DRUG CONTROL STRATEGY, supra note 62, at 11.
Laura Elmore, Protection of Children Exposed to Methamphetamine Production, 71
POPULAR GOV’T 28 (2005); see also Nat’l Alliance for Drug Endangered Children, EvidenceBased Practices and Research, http://www.nationaldec.org/EvidenceBasedPrac&Rsrch/
evidencebasedprac.htm (last visited Jan. 23, 2007) [hereinafter Evidence-Based Practices and
Research] (containing links to illustrative stories).
70. Evidence-Based Practices and Research, supra note 69.
71. SYNTHETIC DRUG CONTROL STRATEGY, supra note 62, at 41.
72. Id.
73. See Nat’l Alliance for Drug Endangered Children, http://www.nationaldec.org/
states/states.htm (last visited Jan. 23, 2007) (providing information about all states that have DEC
programs in place).
74. Nat’l Alliance for Model State Drug Laws, Home Page, http://www.natlalliance.org (last
visited Feb. 22, 2007).
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provides a valuable service in pulling such data into a collection of works
for the purpose of tracking and facilitating the understanding of regulations
regarding methamphetamine use. The Alliance is committed to the updating and maintaining of the information provided over their website for
content accuracy. The information presented herein, regarding state regulations of pseudoephedrine and ephedrine products, draws heavily on the
work of the Alliance. The authors here recognize that no amount of thanks
is sufficient to express our gratitude for the work produced and available
from the Alliance in collecting, organizing, and disseminating information
of this type.
A. MISSION OF THE ALLIANCE
The National Alliance for Model State Drug Laws is an information
portal for “governors, state legislators, attorneys general, drug and alcohol
professionals, community leaders, the recovering community, and others
who strive for comprehensive, effective state drug and alcohol laws and
policies.”75 The Alliance provides several services such as drafting,
researching, and analyzing model drug and alcohol laws and related state
statutes; provides access to a national network of drug and alcohol experts;
and facilitates working relationships among state and community leaders
and drug and alcohol professionals.76
B. FORMING THE ALLIANCE
The Alliance is a nonprofit organization that serves as an ongoing
resource on the model laws and related state legislation.77 It is funded by
Congressional appropriations, and, in coordination with the Office of
National Drug Control Policy, it holds state model drug law Summits across
the country.78 These events are designed to educate state officials about the
model laws and policies.79
VI. STATE SPECIFIC PROVISIONS
As previously noted, while federal legislation such as the CMEA, the
Patriot Act and the SDCS were being considered and created, the majority
of states enacted laws that placed restrictions on the sale of

75. Nat’l Alliance for Model State Drug
http://www.natlalliance.org (last visited Feb. 22, 2007).
76. Id.
77. Id.
78. Id.
79. Id.

Laws,

About

the

Alliance,
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methamphetamine precursors, especially pseudoephedrine. To support
comparisons made throughout this section, a review of the 2005 state
statutes and/or regulations establishing or enhancing restrictions on the
over-the-counter sales of ephedrine and/or pseudoephedrine products was
conducted utilizing information available from the Alliance website.80
A. FEDERAL DRUG SCHEDULE UTILIZED
In order to appropriately discuss state approaches to drug schedules, it
is useful to briefly survey the federal drug schedule, because doing so will
provide a common starting ground for a discussion of state methods. The
Comprehensive Drug Abuse Prevention and Control Act 81 was enacted in
1970.82 Title II of this Act is the Controlled Substances Act (CSA), which
is the legal foundation of narcotics enforcement in the United States.83 The
CSA places all drugs into one of five classifications or schedules.84
Schedule I drugs carry a high tendency for abuse and have no accepted
medical use. Pharmacies do not sell Schedule I drugs and they are not
available even with a prescription.85 Examples include Lysergic acid diethylamide (LSD), methylenedioxymethamphetamine (MDMA or Ecstasy)
and gamma hydroxybutyrate (GHB).
Schedule II drugs also have a high tendency for abuse but do have an
accepted medical use.86 These drugs can produce a dependency or addiction with chronic use.87 This schedule includes examples such as cocaine,

80. Nat’l Alliance for Model State Drug Laws, Regional Comparative Charts—2005 Enacted
Ephedrine and Pseudoephedrine Legislation, available at http://www.natlalliance.org/
publications.asp (last visited Feb. 22, 2007) [hereinafter Regional Comparative Charts—2005
Enacted Ephedrine and Pseudoephedrine Legislation]; OVERVIEW OF STATE LEGISLATIVE/
REGULATORY RESTRICTIONS ON OVER-THE-COUNTER SALES/PURCHASES OF PRODUCTS
CONTAINING PSEUDOEPHEDRINE, available at http://www.natlalliance.org/publications.asp (last
visited June 6, 2007) [hereinafter OVERVIEW OF STATE LEGISLATIVE/REGULATORY
RESTRICTIONS]. One may well expect that the state-by-state information provided herein will be
altered for many states during the next applicable legislative session to comply with the recently
enacted federal law or to increase restrictions. Thus, the data provided here is for a comparison
basis only and is not to be relied on as absolute; this is an area of rapid legislative and regulatory
change. Additionally, the state specific information that follows is date sensitive material and
current only through June 6, 2007.
81. Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91-513, 84
Stat. 1242, 1236.
82. Id.
83. U.S. DRUG ENFORCEMENT ADMIN., THE CONTROLLED SUBSTANCES ACT, available at
http://www.usdoj.gov/dea/pubs/abuse/1-csa.htm (last visited June 12, 2007).
84. 21 U.S.C. § 812 (2006).
85. 21 U.S.C. § 812(b)(1) (2006).
86. 21 U.S.C. § 812(b)(2) (2006).
87. Id.
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amphetamines, and morphine.88 These drugs are available by prescription
and require stringent record keeping and storage.89 There are no refills
permitted on drugs prescribed in this class; instead, the patient must get a
new prescription each time.90
Schedule III drugs have less potential for abuse or addiction and have
an accepted medical use.91 This category includes anabolic steroids, hydrocodone (in combination with aspirin or acetaminophen), and codeine.92
Schedule III drugs are available with a valid prescription, which may be
refilled up to five times in six months, and may be stored among lesser
controlled products on open shelves within the prescription department.93
Schedule IV drugs have a low potential for abuse or addiction and have
an accepted medical use.94 Schedule IV examples include Valium, Xanax,
and phenobarbital, and are available by prescription.95
Schedule V drugs have an even lower potential for abuse or
dependence.96 There is less chance of addictive side effects and they have a
current medical use.97 This schedule includes such drugs as cough
suppressants with codeine.98 Schedule V drugs are regulated and not
typically found in over-the-counter areas, but do not require a prescription
in most states.99
B. STATE SCHEMES
The federal government’s five schedule scheme for classifying
substances subject to potential abuse has been adopted by the states in their
statutes and regulations. Until recently, ephedrine and pseudoephedrine
were not included in any state listing of scheduled drugs subject to
restricted distribution. These methamphetamine precursors were unregulated and readily available at any time of the day, and every day of the week
at locations ranging from pharmacies to roadside mom-and-pop gas stations
and convenient stores.

88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.

21 U.S.C. § 812(c) (2006).
21 U.S.C. § 829(a) (2006).
Id.
21 U.S.C. § 812(b)(3)(2006).
21 U.S.C. § 812(c) (2006).
21 U.S.C. § 829(b) (2006).
21 U.S.C. § 812(b)(4) (2006).
21 U.S.C. § 829(b) (2006).
21 U.S.C. § 812(b)(5) (2006).
Id.
21 U.S.C. § 812(c) (2006).
21 U.S.C. § 829(c)-(d) (2006).
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The DEA has the federal statutory authority to place abusable
medications in one of the appropriate schedules, but in doing so must
consult with the Secretary of Health and Human Services.100 The latter
official, typically with input from both the United States Food and Drug
Administration and the National Institute on Drug Abuse, a division of the
National Institutes of Health, will make a recommendation based on the
potential for abuse associated with the substance.
Many states have included the targeted methamphetamine precursors,
ephedrine and pseudoephedrine, into the Schedule V classification, in an
effort to regulate acquisition and possession. There are a few states that
have taken an even stronger regulatory stance by placing methamphetamine
precursors into the more stringent classifications like Schedule IV,
Schedule III and even Schedule II.
1.

Precursors

As a major part of this law review project, the authors, utilizing
information provided by the Alliance, reviewed the regulating schemes in
all fifty states, plus the District of Columbia.101 The following list identifies
the states that have regulated the acquisition of ephedrine and pseudoephedrine (“precursors”). The actual schedule that these precursors were
assigned by each state is indicated. If the precursors are treated differently,
this has been indicted following the states identification (“*” signifies that
only ephedrine is regulated, and “**” signifies only pseudoephedrine is
regulated).
Schedule II: Colorado*, Idaho, Louisiana, Washington
Schedule III: Nevada, South Dakota*
Schedule IV: Missouri, Nebraska*, Oklahoma*, Oregon, Wisconsin*
Schedule V: Arkansas, Illinois, Iowa, Kansas, Minnesota, Missouri,
New Mexico, Oklahoma, West Virginia, Wisconsin
A majority of states do have written exemptions from the Schedule V
provisions. These include solid oral dosage forms and soft gelatin caplets
formulated pursuant to FDA regulations and packaged in two dose blister
packs. However, most manufacturers have ceased production of such
blister packs rendering the exemptions mute.

100. 21 USC § 811(a)-(b) (2006).
101. Legislative Chart (Jan. 2007), available at www.natlalliance.org/pdfs/
Legislative%20Chart%20January%202.pdf; Regional Comparative Charts—2005 Enacted
Ephedrine and Pseudoephedrine Legislation, supra note 80.
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Although states not included above continue to allow precursors to
remain as unscheduled substances, the overwhelming majority have
recently enacted point of sale restrictions on ephedrine and/or
pseudoephedrine. Many, if not all, of the states referenced above have
enacted both schedule provisions and point of sale restrictions.
2.

Point of Sale Restrictions

“Point of Sale Restrictions” (POS restrictions) is a term which
describes those particular state laws or regulations that place restrictions on
ephedrine, pseudoephedrine and products containing such active ingredients
at the point at which they are sold.102 POS Restrictions can include quantity
restrictions, packaging restrictions, placement within a store, record
keeping, etc. State lawmakers have selected from the non-inclusive list of
POS restrictions as they have deemed appropriate for their constituents.
A higher level of restriction would, of course, be to make chemical
precursors available only by prescription. The Durham-Humphrey Amendment to the Federal Food, Drug and Cosmetic Act103 was enacted in the
early 1950s to clarify the distinction between those medications available
without a prescription and those requiring professional supervision of their
use and, hence are only available by prescription.104 It has also been
suggested that intermediate levels of control should be established involving either an authorized prescriber’s request for initial dispensing with
refills available at the discretion of the pharmacist, or an approach under
which both initial authorization for dispensing and that for refills would be
controlled by the pharmacist.105
The aim of most POS restrictions is to reduce the availability of
ephedrine and pseudoephedrine as methamphetamine precursors. A reduction in precursor availability would be the catalyst to reduce the number of
methamphetamine laboratories, reduce the amount of methamphetamine
available for street purchase, and reduce the number of methamphetamine
associated fatalities and child endangerment cases. In addition, creating a
tracking system that would provide a reach back assessment including, how
baseline methamphetamine use is established, where the majority of

102. Legislative Chart 1, supra note 101.
103. Pub. L. No. 82-215, 65 Stat. 648 (1951) (codified as amended at 21 U.S.C. § 353
(2000)).
104. 21 U.S.C. § 353(b) (2000).
105. Maven J. Myers & Joseph L. Fink III, Legal Considerations in Establishing Third and
Fourth Classes of Drug Products, 31 F.D.C.L.J. 4, 4-10 (1976).
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methamphetamine is being produced, and the methamphetamine laboratory
entrepreneur profile, seems a worthy task.
As mentioned previously, most states have enacted POS restrictions
even if they have not added methamphetamine precursors specifically to a
schedule. The statutes and regulations of all fifty states, plus the District of
Columbia, were reviewed to tabulate the following list of states that have
enacted POS restrictions regarding the acquisition of ephedrine and
pseudoephedrine containing products.106 Any special provisions or current
proposed legislation to amend restrictions, presumably to enhance
restrictions, are indicted as “AP” following the state’s identification.
a. Jurisdictions that currently have no POS restrictions in place:
Connecticut, District of Columbia, Maryland, Massachusetts,
New Hampshire, New York, Pennsylvania, and Rhode Island
b. States that restrict quantity: California, Kansas, Kentucky,
New Jersey, New Mexico, Utah, and Wisconsin
c. State that restricts packaging: Nevada
d. State that restricts quantity and packaging: Arkansas
e. States that restrict quantity and display/offer advertising:
Arizona (AP), Delaware, Florida, Hawaii (AP), Idaho,
Louisiana, Michigan (also bans internet and mail order sales),
Michigan, Missouri, Montana, Ohio, Oklahoma, Pennsylvania,
South Dakota (AP), Tennessee, Texas, Vermont, Virginia,
Washington, and West Virginia (AP)
f. States that restrict quantity, packaging, and display/offer
advertising: Alabama, Alaska, Colorado, Georgia, Illinois,
Indiana, Iowa, Maine, Minnesota, Mississippi, Nebraska, North
Carolina, North Dakota, South Carolina, and Wyoming
In addition, Connecticut has pending legislation that would place
ephedrine and pseudoephedrine in the Schedule V classification. New
Hampshire has pending legislation that would result in the requirement of a
prescription for the purchase of these methamphetamine precursors.
3.

Purchaser Requirements

Some state laws provide restrictions as to those able to purchase
ephedrine and pseudoephedrine products, as well as how the products must

106. Regional Comparative Charts—2005 Enacted Ephedrine and Pseudoephedrine
Legislation, supra note 80; Legislative Chart, supra note 101.

1236

NORTH DAKOTA LAW REVIEW

[VOL . 82:1217

be purchased. The following is a list of current purchaser requirements and
the number of states that utilize that particular restriction/provision.107
a. Purchaser must show proof of identity using a valid photo
identification instrument (generally a driver’s license or some
other government or school issued identification: Alabama,
Arkansas, California, Delaware, Iowa, Kansas, Kentucky,
Louisiana, Maine, Minnesota, Mississippi, Missouri, Montana,
Nebraska, North Carolina, Oklahoma, Oregon, Tennessee,
Texas, Virginia, Washington, West Virginia, and Wisconsin
b. Minimum age to purchase is sixteen years old: Texas
c. Minimum age to purchase is eighteen years old: Alabama,
Arkansas, California, Delaware, Kentucky, Minnesota,
Missouri, Nebraska, North Carolina, North Dakota,
Washington, West Virginia, and Wisconsin
d. Purchaser must sign a written/electronic log or record of
receipt of the individual sales transaction which is maintained
by the seller: Alabama, Arkansas, Delaware, Iowa, Kansas,
Kentucky, Louisiana, Minnesota, Montana, North Carolina,
Oklahoma, Tennessee (only written), Texas, Virginia, West
Virginia, and Wisconsin
e. Log or record requirement exists but does not require the
purchaser to sign: Indiana (no logging of convenience
packages and records must be in accordance with format
approved by state police), Maine (log is voluntary), Michigan
(log is required only if the products are not stored behind a
counter or in a locked case), Oregon, South Dakota, and
Tennessee
4. People That May Sell or Transfer Ephedrine and
Pseudoephedrine Products
Although specific, the regulations governing those allowed to sale or
transfer methamphetamine precursors vary from state to state.108
a. A pharmacy, pharmacist, pharmacy technician, pharmacy
intern or clerk in compliance with the law: Arkansas, Iowa,
Kansas, Kentucky, Maine, Minnesota, Missouri, Oklahoma
(licensed pharmacist or registered pharmacy technician only),
Tennessee, and Wisconsin
107. Regional Comparative Charts—2005 Enacted Ephedrine and Pseudoephedrine
Legislation, supra note 80.
108. Id.
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b. A pharmacy OR any retail establishment: Colorado, Delaware,
Florida, Georgia, Hawaii, Indiana, Louisiana, Michigan,
Mississippi, Nebraska (must also be eighteen years old to sell
products), New Jersey, North Carolina, North Dakota, South
Dakota, Virginia
c. A pharmacy OR a certified/authorized retail establishment in
compliance with the law: California, Montana, Texas, and
Washington (sellers must be licensed by or registered with the
Department of Health)
5.

Retailer/Wholesaler/Manufacturer Registration

A few states have enacted regulations that require a retailer, wholesaler
and/or manufacturer of products containing ephedrine or pseudoephedrine
to register with the defined state authority regarding the handling of such
products.109
a. Wholesalers that are not already licensed: Georgia and West
Virginia
b. Those that are not licensed by the Board of Pharmacy:
Alabama
c. Retailer certification is required: Missouri, Montana,
Washington, and Wyoming
d. A permit is required: California
6.

Placement of Ephedrine and Pseudoephedrine Products

Most states that have enacted placement restrictions have required only
one of the following methods be utilized.110 However, this does not rule
out the contingency that in certain circumstances some combination could
be required. Also, many retailers have taken it upon themselves to
voluntarily apply these methods in specific combinations that work for their
specific retail chain.
a. Behind the counter or in an area that is not accessible to the
public: Alabama, Arkansas (sole active product only),
Delaware, Florida (sole active product), Georgia (sole active is
pseudoephedrine), Hawaii, Indiana, Iowa, Maine, Michigan,
Minnesota, Mississippi, Montana, Nebraska, North Dakota

109. Id.
110. Id; OVERVIEW OF STATE LEGISLATIVE/REGULATORY RESTRICTIONS, supra note 80, at
2.
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(sole active products), South Dakota (sole active product),
Texas, Virginia, Washington, and Wyoming
In a locked case: Alabama, Arkansas (sole active products),
Delaware, Hawaii, Indiana, Iowa, Maine, Michigan,
Mississippi, Montana, Nebraska, Oregon (in full view of
pharmacy), South Dakota (sole active product), Tennessee,
Texas, Virginia, West Virginia, and Wyoming
Within an area that is in the direct line of sight of employees:
Hawaii, Indiana, Virginia (multi-active product), and
Wyoming
Within a specific distance of a staffed counter:
i.
Within ten feet: Missouri
ii.
Within twenty feet: Michigan and South Dakota
iii.
Within twenty-five feet: Tennessee
iv.
Within thirty feet: Indiana (for convenience
packages), Louisiana, Maine (for 60 mg single
dose packages only), Mississippi (for multi-active
ingredient products), Texas, Virginia (for multiactive ingredient products), and Wyoming
In an area under constant video surveillance with signage that
warns of surveillance in use: Hawaii, Indiana, Michigan, North
Dakota, Virginia (multi-active product), and Wyoming
Requires use of anti-theft mechanism and/or alarm: Michigan,
South Dakota (for sole and multi-active, liquid, and pediatric
products), Virginia (multi-active products), and Wyoming
Requires use of restrictive shelving which controls dispensing
time frames (allows for product to be released only every
specified amount of time): Indiana and Virginia (multi-active
products)
Only a limited number of packages may be displayed in a
public area:
i.
No more than 1 package of any type/brand: North
Dakota
ii.
No more than 3 packages or 9 grams of each
product can be placed upon shelving at any one
time: Louisiana
iii.
Behind the pharmacy/prescription counter:
Missouri, North Carolina, Oregon (must be only in
view of pharmacy), Texas, and West Virginia
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Quantity Limitations

In addition to purchaser restrictions, many states have addressed the
issue of quantity of methamphetamine precursor product that is available to
consumers.111
a. States with thirty day quantity limitations:
i.
Nine gram limitation: Arkansas, Delaware,
Kentucky, Louisiana, Mississippi, Missouri,
Montana, New Mexico, North Carolina, Ohio,
Oklahoma, Oregon, South Dakota, Tennessee, and
West Virginia
ii.
7.5 gram limitation: Illinois, Iowa, and Wisconsin
iii.
Six gram limitation: Alabama (if purchased with
the “intent to manufacture
methamphetamine”),
and Minnesota
b. States with seven day quantity limitation: Indiana (no more
than three grams, however, convenience packages are exempt),
and Kansas (no more than three packages)
c. Twenty-four hour quantity limitation: Illinois, Iowa (no more
than 360 mg of liquid pseudoephedrine product), Nebraska (no
more than 1,440 mg of pseudoephedrine product), and
Washington (no more than one transaction in a twenty-four
hour period, and no more than two packages or one package
which totals three grams in one sale)
d. Single transaction quantity limitation: Arkansas (no more than
three packages, nine grams, or ninety-six units), Hawaii and
Pennsylvania (no more than three packages or nine grams),
Illinois (no more than two packages), Michigan (no more than
two packages or forty-eight tablets), Missouri (no more than
two packages or six grams of pseudoephedrine as the sole
active ingredient, or no more than three packages or nine
grams of pseudoephedrine when part of a multi-active
ingredient product), and North Carolina (no more than two
packages or six grams)
Interestingly, the single transaction limitation is often combined with a
thirty day quantity limitation. Combining both limitations places a ceiling

111. Highlights—Illinois Methamphetamine Precursor Control Act 1, available at
www.natlalliance.org/pdgs/Illiois%20Act.pdf; OVERVIEW OF STATE LEGISLATIVE/REGULATORY
RESTRICTIONS, supra note 80, at 2, 5, 6; Regional Comparative Charts—2005 Enacted Ephedrine
and Pseudoephedrine Legislation, supra note 80.
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on the amount that a person may sell in a single transaction, plus a cap on
how much can be purchased within a monthly period.
8.

Required Log or Record of Receipt Information

As a general rule, states that mandate that a record be kept of precursor
purchases typically require the log to show the purchaser’s name, date of
the transaction, quantity of the item purchased, and name of product
purchased.112 However, some states require the purchaser’s address,
driver’s license number or other proof of the photo identification provided,
and/or the seller’s initials or signature, as additional information.113
9.

Packing Restrictions

a. Most states require that ephedrine and pseudoephedrine
products be dispensed only if packaged in accordance with the
law.114
b. The following states even require that products containing
methamphetamine precursors be packaged in blister packs or
unit dose packages (two units in each pack) if blister packs are
not feasible: Alabama (30 mg or more), Arkansas, Colorado,
Georgia (sole active product), Illinois, Maine, Minnesota,
Nebraska, North Carolina (30 mg or more of sole active
product), North Dakota, and Wyoming.
c. Additionally, some states place further restrictions upon the
dosage of packing by requiring that no more than two unit
doses be in each pack, and if blister packaging is not feasible,
then the product must be in unit dose pouches or packages.
These states are: Arkansas, Colorado, Illinois, Maine,
Minnesota, Nebraska, North Dakota, and Wyoming.
d. The maximum amount of ephedrine and pseudoephedrine
product allowed in one package is most commonly controlled
by a three gram restriction. However, the following states
imposed the other quantity restrictions: Illinois and Iowa (360
mg liquid products), Indiana (120 mg convenience packages),

112. Specific state references were purposely omitted because the authors chose to
concentrate on more important areas. Please consult the Alliance website for up-to-date
information.
113. Regional Comparative Charts—2005 Enacted Ephedrine and Pseudoephedrine
Legislation, supra note 80.
114. Id.; Highlights—Illinois, supra note 111, at 1.
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Maine (60 mg single dose packages), Nebraska (1,44 g), and
North Dakota (two grams.)
10. Posting of State Law Required in Retail Locations
Only a few states require retail locations selling ephedrine and
pseudoephedrine products to post a copy of the governing state law in the
premises.
These states include: Iowa, Michigan, North Carolina
(purchasers must sign an acknowledgement that references the state’s law
regarding over-the-counter sales), and South Dakota.115
11. Retailer/Employee and Owner/Operator Immunity
Very little has been established in the way of prescribed immunity for
those involved with the sale of ephedrine and pseudoephedrine products.
However, the few states that have addressed this issue in limited regard
include: Georgia, Massachusetts, and North Carolina.116
a. For injuries resulting from sales of regulated products: South
Dakota
b. For compliance with laws: Alabama, Indiana, Maine, North
Carolina, and Washington
c. For employee training: Alabama, Georgia, Michigan (at the
time of citation the defendant must have a written policy in
place for employees to prevent illegal sales), Minnesota,
Mississippi, North Dakota, and Wisconsin
d. If employee signs acknowledgement of restrictions: Louisiana
As of the time of this writing, no circumstances were noted where the
limits of these immunity grants had been challenged.
VII. PRE-EMPTIONS AND EXEMPTIONS
A. STATE LAW PREEMPTION
In many states, the legislation enacted pre-empted any municipalities
that had imposed restrictions regarding the sale or purchase of over-thecounter products, which were more restrictive than those provisions
imposed under the state law. This type of preemption affected the
following states: Alabama, Arizona, California, Florida, Georgia, Indiana,

115. Id.
116. Id.
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Iowa, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Missouri, North
Carolina, North Dakota, South Dakota, Tennessee, and Texas.117
Localities and municipalities may still impose restrictions. However,
ephedrine and pseudoephedrine products may not be regulated in any way
that is more or less restrictive than the active state law.
B. EFFECTIVE DATES
In 2005, thirty-three states passed provisions establishing or amending
restrictions on over-the-counter sales of products containing ephedrine and
pseudoephedrine.118 In February 2005, Arkansas and South Dakota were
the first to establish or amend restrictions. In March 2005, Iowa and
Kentucky agreed that restrictions were needed. In April 2005, Tennessee
and West Virginia joined in. In May 2005, Nebraska did likewise. In June
2005, Delaware, Missouri, New Jersey, and North Dakota enacted
restrictions. In July 2005, Alabama, Colorado, Florida, Georgia, Hawaii,
Indiana, Minnesota, Mississippi, Montana, and Wyoming followed suit. In
August 2005, Louisiana, Oregon, and Texas saw the wisdom in passing
similar restrictions. In October 2005, Arizona, Maine, Virginia, and
Wisconsin agreed that restrictions were needed. Oklahoma did likewise in
November 2005. Michigan accomplished the same in December, before
2005 ended. In January 2006, California, North Carolina, and Washington
followed the previous states in enacting restrictions.
C. EXEMPTIONS AND/OR EXCEPTIONS TO RESTRICTIONS ON THE
SALE/TRANSFER OR PURCHASE OF PRECURSORS
Even with all of the restrictions that have been established by
legislation there are, as always, a myriad of exceptions. The following is a
list of the current exemptions from governmental restrictions:
1. Purchaser presents a valid prescription;119
2. The product is sold/transferred, purchased, or possessed in that
person’s legitimate and authorized (lawful) course of business
(i.e., pharmacies, physicians, common transit carriers,
manufactures, and distributors);120
3. Liquid products;121
117. Id.
118. Id.
119. Regional Comparative Charts—2005 Enacted Ephedrine and Pseudoephedrine
Legislation, supra note 80.
120. Id.
121. Id. This category includes liquid capsules and liquid gelcaps. Id. The majority of
states have exempted ephedrine and pseudoephedrine products in the over-the-counter liquid
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4.

Pediatric products intended for administration to children
under the age of twelve; 122
5. Products found not to be used in illegal manufacturing or
present no significant risk of use in the manufacturing of
methamphetamine; 123 and
6. Products formulated to prevent diversion.124
Although, the states one by one, began to place restrictions on the sale
of ephedrine and pseudoephedrine products, individual state regulation left
many opportunities for methamphetamine producers to shop state lines as
well as multiple locations for their ingredients. Handwritten logs are not
sufficient for maintaining any cross reference database to check buyers
within a region. The mass diversity in approaches among states provided a
good environment for political and legal discussion, but the outcome was a
failure due to the void in tracking ability across regions and the limited
deterrence it provided.
VIII. ALTERNATIVES FOR PHARMACEUTICAL MANUFACTURERS
AND RETAILERS
As a result of the increasing regulatory restrictions on the sale and
distribution of products containing ephedrine and pseudoephedrine, many
pharmaceutical manufacturing companies tried to address the public
concerns and save their own marketing strategies.125 The pharmaceutical
manufacturing companies such as Pfizer and Leiner health products did this
by pulling their products off the market, reducing their decongestant
inventory available, and/or reformulating products to use alternative
decongestants such as phenylephrine.126

formulation from POS restrictions, but have authorized a state agency to enact regulation of liquid
product forms if diversion and conversion for use in manufacturing of methamphetamine becomes
evident. Id. Some states have utilized the authority to impose tighter regulation on liquid
formulations. Id. In these more restrictive states, some of the restrictions that apply to liquid
product forms include: products where ephedrine or pseudoephedrine is not the sole active
ingredient, allowable but only in small or low dosage, and/or have placed a limit on the amount
that can be sold in a single transaction. Id.
122. Regional Comparative Charts—2005 Enacted Ephedrine and Pseudoephedrine
Legislation, supra note 80. At times there may be single dose limit restriction placed upon these
pediatric products for the exemption to be applicable (e.g., no more than ten mg for a solid or
liquid product). Id.
123. Id.
124. Id. This exemption is most commonly granted to a manufacturer only. Id.
125. See Donna Leinwand, Drugmakers Take Action to Foil Methamphetamine Cooks, USA
TODAY, June 28, 2005, available at http://www.usatoday.com/news/health/2005_06_28_
methamphetamine_x.htm.
126. Id.
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Phenylephrine
Source: structure taken from Remington.127
Both pseudoephedrine and phenylephrine work to reduce congestion,
but pseudoephedrine is considered to be more effective.128 However, many
consumers remain upset and confused over the variability in product,
procedure and regulation from retailer to retailer and across state lines. Are
manufactures assuming consumer ignorance? Just switch ingredients, put it
in a very similar box, in a very similar spot and no one will notice or question. There is a lack of advertisements that exclaim that phenylephrine is
just as good as pseudoephedrine or that offer any explanation for the switch.
Admittedly, these are not required, especially for over-the-counter products.
However, pseudoephedrine is no average over-the-counter product anymore. Additionally, with such national recognition and consumer confusion
would it not be progressive for a manufacturer who benefited in the
millions of dollars from consumer loyalty to inform and educate their
customers? Maybe the manufacturers are leaving education of consumers to
the retailers and pharmacists.
In response to a national outcry for control, the Bush Administration
stepped forward with its enactment of federal legislation and policy through
CMEA and SDCS to address the methamphetamine epidemic.129 One may
speculate that current drug policy restrictions are more politically motivated
than socially motivated. If so, then current policy in fact might cause a shift
of supply that is actually more in favor of large scale criminal organizations
to meet demand. However, with the enactment of a federal law there exists
a possibility to develop a national database for monitoring pseudoephedrine
127. REMINGTON, supra note 14, at 1381.
128. Bruce Buckley, Where’s My Cold Medicine? PSE: Impact of Behind-the-Counter
Placement, PHARMACY TODAY OTC SUPPLEMENT 4 (Feb. 2006).
129. Combat Methamphetamine Epidemic Act of 2005, Pub. L. No. 109-177, 120 Stat. 256
(2006); SYNTHETIC DRUG CONTROL STRATEGY, supra note 62, at 1.
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purchases by individuals across state lines. Currently, several states are
addressing the development of computerized tracking systems to monitor
pseudoephedrine containing products.
Walgreen’s, a pharmacy chain, has recently designed an electronic
database to track sales of medications that can be used to make methamphetamine.130 This database goes beyond the one first introduced by WalMart which only accounted for individual store sales.131 Walgreen’s
computerized tracking system has replaced the old paper records that were
considered by most to be ineffective in tracking individual sales and
profiling methamphetamine makers.132 Walgreens customers who buy the
targeted products must provide photo identification and sign a log.133
Employees trained on the system then enter the customer and sales
information into the tracking system which is tied into the cash registers
and pharmacy database.134 Because Walgreens pharmacy database is
nationwide, this improved record keeping allows the first nationwide
methamphetamine precursor tracking.135 Such a nationwide database is an
important tool to prevent methamphetamine makers from circumventing
pseudoephedrine restrictions by traveling among stores within a region.
Applause goes out to Walgreens for absorbing the cost of innovation to
further the cause and improve community ties.
IX. THE UNKNOWN
Monitoring pharmaceutical manufacturers raises some patient privacy
issues which are left for additional research and discussion. For example,
in late 2005, Tennessee law enforcement officials began posting the names
of convicted methamphetamine manufacturers on a website, called the
Methamphetamine Offender Registry.136 This database is modeled after the
sex offender registry and allows users to enter a name or county to receive a
display of those convictions in the region.137 Other issues include

130. Valerie Dowdle, AG Touts Tracking of Meth Ingredient, MEDILL NEWS SERVICE, July
3,
2006,
available
at
http://www.thetimesonline.com/articles/2006/07/03/news/illiana/
541537b1ac72df558625719f00818eef.txt.
131. Id.
132. Id.
133. Id.
134. Id.
135. Id.
136. Ellen Barry, Tennessee Posts Convicted Methamphetamine Makers on Web,
http://www.latimes.com/news/nationworld/nation/la-na-registry30dec30,1,1393837.story
(last
visited Jan. 4, 2006).
137. Id.
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controlling the accuracy of information collected, response time, and retail
price increases.
Of course, the CMEA is a federal law and thus provides only a floor of
restriction. Individual states remain capable of imposing stricter guidelines
and addressing areas untouched by the federal law. In light of such
governmental structure and power, certain issues like precursor classification, scripting, samples, and posting are important. If precursors are
classified as Schedule II through V, they will require a valid written
prescription. This places the burden of a medically necessary evaluation
and determination upon the physician and/or pharmacists as is required by
the DEA for drugs in these classes.
Depending upon the specific classification, the provision may require
that the patient physically meet with the physician for each new prescription
rather that merely having the doctor call the prescription into the pharmacy
without a face-to-face meeting. In addition, how the law will affect free
drug samples permitted by a physician is yet to be seen. It is also unknown
whether the physician will have to log such samples for tracking
regulations.
Because the states will remain free to adjust the restrictions, and
considering the outrage that has been expressed by numerous consumers
regarding the time and hassle created by the restrictions and logging
requirements, perhaps mandatory posting of state and federal law would be
appropriate. These posting rules would be comparable to the employment
or surveillance notices that are already in place for retailers. However, it
seems most consumer frustration has been directed toward the retail
establishments and not at the legislature. Therefore, there may be a political
motive for not mandating the requirements be posted.
And while it is yet to be seen just how much CMEA will impede the
spread of the methamphetamine epidemic, the impact on consumer access
to cold products has been substantial. This is especially true in remote
areas, which are serviced by a limited number of pharmacies with limited
hours of operation. Consumers could be further inconvenienced by having
a mandatory pharmacist consult imposed. Restrictions on pseudoephedrine
could also increase the dangers of polypharmacy and/or self-medication as
consumers explore replacements and alternatives.138 The outcomes are to
be revealed, but the American Pharmacists Association and many
pharmacists think that the restrictions open a wonderful opportunity for

138. Polypharmacy is “either the concomitant use of multiple drugs or the administration of
more medications than are indicated clinically.” JOSEPH T. DI PIRO ET AL., PHARMACOTHERAPY:
A PATHOPHYSIOLOGIC APPROACH 108 (6th ed. 2005).
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both consumers and pharmacists to interact more regarding use of cough/
cold and allergy medications which are among the most widely used nonprescription products sold in pharmacies.139 Pharmacists can help consumers understand why the ephedrine and pseudoephedrine products were
moved, how to use the medications safely, and to properly store an on hand
supply for times when the pharmacy may be closed.
X. CONCLUSION
Regardless of the pros and cons of legal restrictions on methamphetamine, a person is hard pressed to not recognize that methamphetamine
abuse is a great problem in the United States. State and local authorities are
kept so busy responding to domestic laboratories which have the potential
to cause explosions, fires, and death, that they are unable to maintain
monitoring over larger drug traffickers bringing methamphetamine and
precursors across state lines. Time had long past for recognition of this
epidemic in federal legislation and policy like that found in the CMEA and
SDSC. It is yet to be seen what loopholes, if any, remain in the CMEA.
Although a deep financial burden is placed upon the government and its
taxpayers, some national control measures, including tight regulation of
pseudoephedrine products nationwide, are a reasonable way to curtail the
methamphetamine problem and place a damper upon the activities of
domestic laboratories that have proven to be so toxic and dangerous to the
communities in which they operate.
The authors’ concern is that even if the restrictions eliminate the
estimated small percent of the methamphetamine supplied by domestic
laboratories using pseudoephedrine products obtained from retailers, what
effect will there be on the remaining large percent produced by super
laboratories in Mexico and brought into the United States by criminal
organizations in truckloads. The Bush Administration believes that it has
addressed this concern with the enactment of the SDCS and its three tiered
approach to reduce the amount of methamphetamine and precursors that are
brought across United States borders. There will probably be many people
watching and monitoring the effect of the SDCS. The area of methamphetamine legislation has no doubt embarked upon its historic journey, but
remains in its infancy. For those intrigued by law making and the political
process the methamphetamine journey will prove to be an interesting one.

139. Bruce Buckley, supra note 128, at 14.

